Male breast cancer - An andrological disease: Risk factors and diagnosis

Andrologia

Volumn 36, Issue 6, 2004, Pages 346-354

  Krause, W ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

Andrological disease; Diagnosis; Male breast cancer; Risk factors; Treatment

Indexed keywords

BREAST CANCER; CANCER PATIENT; ECHOGRAPHY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GYNECOMASTIA; HUMAN; HYPERPROLACTINEMIA; MALE; MALE BREAST; MALE GENITAL SYSTEM DISEASE; MAMMOGRAPHY; NEEDLE BIOPSY; POSITRON EMISSION TOMOGRAPHY; REVIEW; RISK FACTOR; SCINTIGRAPHY;

BREAST NEOPLASMS, MALE; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HUMANS; MALE; RISK FACTORS;

EID: 9144257411     PISSN: 03034569     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0272.2004.00639.x     Document Type: Review

References (106)

1. Altinli E, Gorgun E, Karabicak L, Uras C, Unal H, Akcal T (2002) Anthropometric measurements in male breast cancer. Obes Surg 12:869-870.
2. Ambrogetti D, Ciatto S, Catarzi S, Muraca MG (1996) The combined diagnosis of male breast lesions: a review of a series of 748 consecutive cases. Radiol Med (Torino) 91:356-359.
3. Amir H, Makwaya CK, Moshiro C, Kwesigabo G (1996) Carcinoma of the male breast: a sexually transmitted disease? East Afr Med J 73:187-190.
4. Appelbaum AH, Evans GF, Levy KR, Amirkhan RH, Schumpert TD (1999) Mammographic appearances of male breast disease. Radiographics 19:559-568.
5. Baba M, Higaki N, Ishida M, Kawasaki H, Kasugai T, Wada A (2002) A male patient with metachronous triple cancers of small cell lung, prostate and breast. Breast Cancer 9:170-174.
6. Backe J (2002) Brustkrebs beim Mann. Dtsch Ärztebl 99:970-972.
7. Basham VM, Lipscombe JM, Ward JM, Gayther SA, Ponder BA, Easton DF, Pharoah PD (2002) BRCA1 and BRCA2 mutations in a population-based study of male breast cancer. Breast Cancer Res 4:R2.
8. Bernard-Gallon DJ, Dechelotte PJ, Le Corre L, Vissac-Sabatier C, Favy DA, Cravello L, De Latour MP, Bignon YJ (2003) Expression of BRCA1 and BRCA2 in male breast cancers and gynaecomastias. Anticancer Res 23:661-667.
9. Bock K, Iwinska-Zelder J, Duda VF, Bonwetsch C, Rode G, Hadji P, Klose KJ, Schulz KD (2001) Validity of the breast imaging reporting and data system BI-RADS(TM) for clinical mammography in men. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 173:1019-1024.
10. Boyd J, Rhei E, Federici MG, Borgen PI, Watson P, Franklin B, Karr B, Lynch J, Lemon SJ, Lynch HT (1999) Male breast cancer in the hereditary nonpolyposis colorectal cancer syndrome. Breast Cancer Res Treat 53:87-91.
11. Brainard GC, Kavet R, Kheifets LI (1999) The relationship between electromagnetic field and light exposures to melatonin and breast cancer risk: a review of the relevant literature. J Pineal Res 26:65-100.
12. de Bree E, Askoxylakis J, Giannikaki E, Chroniaris N, Sanidas E, Tsiftsis DD (2002) Secretory carcinoma of the male breast. Ann Surg Oncol 9:663-667.
13. Capacci F, Carnevale F (2000) Male breast tumors in railway engine drivers: investigation of 5 cases. Ann Ist Super Sanita 36:375-379.
14. Cocco P, Figgs L, Dosemeci M, Hayes R, Linet MS, Hsing AW (1998) Case-control study of occupational exposures and male breast cancer. Occup Environ Med 55:599-604.
15. D'Avanzo B, La Vecchia C (1995) Risk factors for male breast cancer. Br J Cancer 71:1359-1362.
16. Daly PA, Nolan C, Green A, Ormiston W, Cody N, McDevitt T, O'hIci B, Byrne D, McDermott E, Carney DN, O'Higgins N, Barton DE (2003) Predictive testing for BRCA1 and 2 mutations: a male contribution. Ann Oncol 14:549-553.
17. Daniels IR, Layer GT (2003) Testicular tumours presenting as gynaecomastia. Eur J Surg Oncol 29:437-439.
18. Deacon SJ, Walker RA, Rew DA (1997) Ductal carcinoma in situ in the male breast presenting as a profuse watery nipple discharge: a case report. Eur J Surg Oncol 23:569.
19. Denic S, Al-Gazali L (2002) Breast cancer, consanguinity, and lethal tumor genes: simulation of BRCA1/2 prevalence over 40 generations. Int J Mol Med 10:713-719.
20. Donegan WL (2000) Cancer of the male breast. J Gend Specif Med 3:55-58.
21. El Saghir NS, Shamseddine AI, Geara F, Bikhazi K, Rahal B, Salem ZM, Taher A, Tawil A, El Khatib Z, Abbas J, Hourani M, Seoud M (2002) Age distribution of breast cancer in Lebanon: increased percentages and age adjusted incidence rates of younger-aged groups at presentation. J Med Liban 50:3-9.
22. Emoto A, Nasu N, Mimata H, Nomura Y, Mizokuchi H, Wada M (2001) A male case of primary bilateral breast cancers during oestrogen therapy for prostate cancer. Nippon Hinyokika Gakkai Zasshi 92:698-701.
23. Erren TC (2001) A meta-analysis of epidemiologic studies of electric and magnetic fields and breast cancer in women and men. Bioelectromagnetics (Suppl 5):105-119.
24. Eubank WB, Mankoff DA, Takasugi J, Vesselle H, Eary JF, Shanley TJ, Gralow JR, Charlop A, Ellis GK, Lindsley KL, Austin-Seymour MM, Funkhouser CP, Livingston RB (2001) 18 fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer. J Clin Oncol 19:3516-3523.
25. Evans DG, Bulman M, Young K, Gokhale D, Lalloo F (2001a) High detection rate for BRCA2 mutations in male breast cancer families from North West England. Fam Cancer 1:131-133.
26. Evans GF, Anthony T, Turnage RH, Schumpert TD, Levy KR, Amirkhan RH, Campbell TJ, Lopez J, Appelbaum AH (2001b) The diagnostic accuracy of mammography in the evaluation of male breast disease. Am J Surg 181:96-100.
27. Ewertz M, Holmberg L, Tretli S, Pedersen BV, Kristensen A (2001) Risk factors for male breast cancer - a case-control study from Scandinavia. Acta Oncol 40:467-471.
28. Feychting M, Forssen U, Rutqvist LE, Ahlbom A (1998) Magnetic fields and breast cancer in Swedish adults residing near high-voltage power lines. Epidemiology 9:392-397.
29. Forloni F, Giovilli M, Pecis C, Bortolani E, Preziosi A, Barzaghi ME, Corti D, Beck-Peccoz P (2001) Pituitary prolactin-secreting macroadenoma combined with bilateral breast cancer in a 45-year-old male. J Endocrinol Invest 24:454-459.
30. Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, Lingenfelter B, Gumpper KL, Scholl T, Tavtigian SV, Pruss DR, Critchfield GC (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10 000 individuals. J Clin Oncol 20:1480-1490.
31. Ganly I, Taylor EW (1995) Breast cancer in a trans-sexual man receiving hormone replacement therapy. Br J Surg 82:341.
32. Gatalica Z, Norris BA, Kovatich AJ (2000) Immunohistochemical localization of prostate-specific antigen in ductal epithelium of male breast. Potential diagnostic pitfall in patients with gynaecomastia. Appl Immunohistochem Mol Morphol 8:158-161.
33. Gerber B, Mylonas I (2003) Reduction of the risk of breast cancer. Zbl Gynäkol 125:6-16.
34. Gill MS, Kayani N, Khan MN, Hasan SH (2000) Breast diseases in males - a morphological review of 150 cases. J Pak Med Assoc 50:177-179.
35. Giordano SH, Buzdar AU, Hortobagyi GN (2002) Breast cancer in men. Ann Intern Med 137:678-687.
36. Gola M, Papi G, Tavernari V, Pesenti M, Ficarra G, Velardo A (1997) Mammary carcinoma in a patient with hyperprolactinaemia. Minerva Endocrinol 22:107-110.
37. Gordon DJ, Chin KH, Budny PG, Taylor AR (2003) Male breast cancer in World War II aviation: a case report and review. Breast 12:156-157.
38. Green L, Wysowski DK, Fourcroy JL (1996) Gynaecomastia and breast cancer during finasteride therapy. N Engl J Med 335:823.
39. Gudmundsdottir K, Thorlacius S, Jonasson JG, Sigfusson BF, Tryggvadottir L, Eyfjord JE (2003) CYP17 promoter polymorphism and breast cancer risk in males and females in relation to BRCA2 status. Br J Cancer 88:933-936.
40. Haase D, Binder C, Bunger J, Fonatsch C, Streubel B, Schnittger S, Griesinger F, Westphal G, Schoch C, Knopp A, Berkovicz D, Krieger O, Wormann B, Hilgers R, Hallier E, Schulz T (2002) Increased risk for therapy-associated hematologic malignancies in patients with carcinoma of the breast and combined homozygous gene deletions of glutathione transferases M1 and T1. Leuk Res 26:249-254.
41. Hansen J (2000) Elevated risk for male breast cancer after occupational exposure to gasoline and vehicular combustion products. Am J Ind Med 37:349-352.
42. Hemminki K, Vaittinen P (1999) Male breast cancer: risk to daughters. Lancet 353:1186-1187.
43. Hittmair AP, Lininger RA, Tavassoli FA (1998) Ductal carcinoma in situ (DCIS) in the male breast: a morphologic study of 84 cases of pure DCIS and 30 cases of DCIS associated with invasive carcinoma - a preliminary report. Cancer 83:2139-2149.
44. Hsing AW, McLaughlin JK, Cocco P, Co Chien HT, Fraumeni JF Jr (1998) Risk factors for male breast cancer (United States). Cancer Causes Control 9:269-275.
45. Hultborn R, Hanson C, Kopf I, Verbiene I, Warnhammar E, Weimarck A (1997) Prevalence of Klinefelter's syndrome in male breast cancer patients. Anticancer Res 17:4293-4297.
46. Izatt L, Greenman J, Hodgson S, Ellis D, Watts S, Scott G, Jacobs C, Liebmann R, Zvelebil MJ, Mathew C, Solomon E (1999) Identification of germline missense mutations and rare allelic variants in the ATM gene in early-onset breast cancer. Genes Chromosomes Cancer 26:286-294.
47. Janin N, Andrieu N, Ossian K, Lauge A, Croquette MF, Griscelli C, Debre M, Bressac-de-Paillerets B, Aurias A, Stoppa-Lyonnet D (1999) Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families. Br J Cancer 80:1042-1045.
48. Johnson KC, Pan S, Mao Y (2002) Canadian Cancer Registries Epidemiology Research Group: risk factors for male breast cancer in Canada, 1994-1998. Eur J Cancer Prev 11:253-263.
49. de Jong MM, Nolte IM, te Meerman GJ, van der Graaf WT, Oosterwijk JC, Kleibeuker JH, Schaapveld M, de Vries EG (2002) Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility. J Med Genet 39:225-242.
50. Joshi MG, Lee AK, Loda M, Camus MG, Pedersen C, Heatley GJ, Hughes KS (1996) Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome. Cancer 77:490-498.
51. Joshi A, Kapila K, Verma K (1999) Fine needle aspiration cytology in the management of male breast masses. Nineteen years of experience. Acta Cytol 43:334-338.
52. Jun Yang Y (2002) Gynaecomastia with marked cellular atypia associated with chemotherapy. Arch Pathol Lab Med 126:613-614.
53. Kanaan Y, Kpenu E, Utley K, Adams-Campbell L, Dunston GM, Brody LC, Broome C (2003) Inherited BRCA2 mutations in African Americans with breast and/or ovarian cancer: a study of familial and early onset cases. Hum Genet 113:452-460.
54. Kapila K, Verma K (2003) Cytology of nipple discharge in florid gynaecomastia. Acta Cytol 47:36-40.
55. Karamanakos P, Apostolopoulos V, Fafouliotis S, Mela A, Ziounas Y, Trafalis DT (1996) Synchronous bilateral primary male breast carcinoma with hyperprolactinaemia. Acta Oncol 35:757-759.
56. Khairallah FS, Joyce JM, Myers DT, Organist M (2002) Detection of breast carcinoma in a man on dual-isotope T1-201 and Tc-99m myoview myocardial perfusion imaging. Clin Nucl Med 27:743-744.
57. Kidwai N, Gong Y, Sun X, Deshpande CG, Yeldandi AV, Rao MS, Badve S (2004) Expression of androgen receptor and prostate-specific antigen in male breast carcinoma. Breast Cancer Res 6:R18-23.
58. Koc M, Polat P (2001) Epidemiology and aetiological factors of male breast cancer: a ten years retrospective study in eastern Turkey. Eur J Cancer Prev 10:531-534.
59. Kwiatkowska E, Teresiak M, Breborovvicz D, Mackiewicz A (2002) Somatic mutations in the BRCA2 gene and high frequency of allelic loss of BRCA2 in sporadic male breast cancer. Int J Cancer 98:943-945.
60. Leibowitz SB, Garber JE, Fox EA, Loda M, Kaufman DS, Kantoff PW, Oh WK (2003) Male patients with diagnoses of both breast cancer and prostate cancer. Breast J 9:208-212.
61. Liu M, Husain SS, Hameer HR, Gona JM (1999) Detection of male breast cancer with Tc-99m methoxyisobutyl isonitrile. Clin Nucl Med 240:882-883.
62. Llort G, Munoz CY, Tuser MP, Guillermo IB, Lluch JR, Bale AE, Franco MA (2002) Low frequency of recurrent BRCA1 and BRCA2 mutations in Spain. Hum Mutat 19:307.
63. Lopez-Rios F, Vargas-Castrillon J, Gonzalez-Palacios F, de Agustin PP (1998) Breast carcinoma in situ in a male. Report of a case diagnosed by nipple discharge cytology. Acta Cytol 42:742-744.
64. Luqmani YA, Temmim LL, Mathew M (2002) Loss of heterozygosity and microsatellite instability in male breast cancer. Oncol Rep 9:417-421.
65. Magro G, Bisceglia M, Michal M, Eusebi V (2002) Spindle cell lipoma-like tumor, solitary fibrous tumor and myofibroblastoma of the breast: a clinico-pathological analysis of 13 cases in favor of a unifying histogenetic concept. Virchows Arch 440:249-260.
66. Merkle E, Muller M, Vogel J, Klatt S, Gorich J, Beger HG, Brambs HJ (1996) Clinical relevance of mammography in men. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 164:7-12.
67. Neuhausen SL, Godwin AK, Gershoni-Baruch R, Schubert E, Garber J, Stoppa-Lyonnet D, Olah E, Csokay B, Serova O, Lalloo F, Osorio A, Stratton M, Offit K, Boyd J, Caligo MA, Scott RJ, Schofield A, Teugels E, Schwab M, Cannon-Albright L, Bishop T, Easton D, Benitez J, King MC, Goldgar D (1998) Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study. Am J Hum Genet 62:1381-1388.
68. Neuhausen S, Dunning A, Steele L, Yakumo K, Huffman M, Szabo C, Tee L, Baines C, Pharoah P, Goldgar D, Easton D (2004) Role of CHEK2*1100delC in unselected series of non-BRCA1/2 male breast cancers. Int J Cancer 108:477-478.
69. O'Hanlon DM, Kent P, Kerin MJ, Given HF (1995) Unilateral breast masses in men over 40: a diagnostic dilemma. Am J Surg 170:24-26.
70. Offit K, Pierce H, Kirchhoff T, Kolachana P, Rapaport B, Gregersen P, Johnson S, Yossepowitch O, Huang H, Satagopan J, Robson M, Scheuer L, Nafa K, Ellis N (2003) Frequency of CHEK2*1100delC in New York breast cancer cases and controls. BMC Med Genet 4:1.
71. Olsson H, Bladstrom A, Alm P (2002) Male gynaecomastia and risk for malignant tumours - a cohort study. BMC Cancer 2:26.
72. OMIM (2004) Database of human genes and genetic disorders. Online Mendelian Inheritance in Man [WWW document]. URL http://www.ncbi.nlm.nih.gov/ entrez/query.fcgi?db=OMIM.
73. Ottini L, Masala G, D'Amico C, Mancini B, Saieva C, Aceto G, Gestri D, Vezzosi V, Falchetti M, De Marco M, Paglierani M, Cama A, Bianchi S, Mariani-Costantini R, Palli D (2003) BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy. Cancer Res 63:342-347.
74. Ozdemir A, Oznur II, Vural G, Atasever T, Karabacak NI, Gokcora N, Isik S, Unlu M (1997) T1-201 scintigraphy, mammography and ultrasonography in the evaluation of palpable and nonpalpable breast lesions: a correlative study. Eur J Radiol 24:145-154.
75. Partik B, Mallek R, Rudas M, Pokieser P, Wunderbaldinger P, Helbich TH (2001) Malignant and benign diseases of the breast in 41 male patients: mammography, sonography and pathohistological correlations. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 173:1012-1018.
76. Pollan M, Gustavsson P, Floderus B (2001) Breast cancer, occupation, and exposure to electromagnetic fields among Swedish men. Am J Ind Med 39:276-285.
77. Prechtel K, Prechtel V (1997) Breast carcinoma in the man. Current results from the viewpoint of clinic and pathology. Pathologe 18:45-52.
78. Rauscher GH, Sandler DP, Poole C, Pankow J, Shore D, Bloomfield CD, Olshan AF (2003) Is family history of breast cancer a marker of susceptibility to exposures in the incidence of de novo adult acute leukemia? Cancer Epidemiol Biomarkers Prev 12:289-294.
79. Reinikainen H, Rissanen T, Paivansalo M, Paakko E, Jauhiainen J, Suramo I (2001) B-mode, power Doppler and contrast-enhanced power Doppler ultrasonography in the diagnosis of breast tumors. Acta Radiol 42:106-113.
80. Robinson CF, Petersen M, Sieber WK, Palu S, Halperin WE (1996) Mortality of Carpenters' Union members employed in the U.S. construction or wood products industries, 1987-1990. Am J Ind Med 30:674-694.
81. Rosen EM, Fan S, Goldberg ID (2001) BRCA1 and prostate cancer. Cancer Invest 19:396-412.
82. Rosenblatt KA, Thomas DB, Jimenez EM, Fish B, McTiernan A, Stalsberg H, Stemhagen A, Thompson WD, Curnen MG, Satariano W, Austin DF, Greenberg RS, Key C, Kolonel EN, West DW (1999) The relationship between diet and breast cancer in men (United States). Cancer Causes Control 10:107-113.
83. Rudan I, Rudan N, Strnad M (1995) Differences between male and female breast cancer. I. Epidemiological features. Acta Med Croatica 49:117-120.
84. San Miguel P, Sancho M, Enriquez JE, Fernandez J, Gonzalez-Palacios F (1997) Lobular carcinoma of the male breast associated with the use of cimetidine. Virchows Arch 430:261-263.
85. Schinina V, Busi Rizzi E, Zaccarelli M, Carvelli C, Bibbolino C (2002) Gynaecomastia in male HFV patients MRI and US findings. Clin Imaging 26:309-313.
86. Siddiqui MT, Zakowski MF, Ashfaq R, Ali SZ (2002) Breast masses in males: multi-institutional experience on fine-needle aspiration. Diagn Cytopathol 26:87-91.
87. Sorensen HT, Friis S, Olsen JH, Thulstrup AM, Mellemkjaer E, Linet M, Trichopoulos D, Vilstrup H, Olsen J (1998) Risk of breast cancer in men with liver cirrhosis. Am J Gastroenterol 93:231-233.
88. Spanu A, Dettori G, Nuvoli S, Porcu A, Falchi A, Cottu P, Solinas ME, Scanu AM, Chessa F, Madeddu G (2001) (99)mTc-tetrofosmin SPET in the detection of both primary breast cancer and axillary lymph node metastasis. Eur J Nucl Med 28:1781-1794.
89. Storm HH, Olsen J (1999) Risk of breast cancer in offspring of male breast-cancer patients. Lancet 353:209.
90. Syrjakoski K, Kuukasjarvi T, Auvinen A, Kallioniemi OP (2004) CHEK2 1100delC is not a risk factor for male breast cancer population. Int J Cancer 108:475-476.
91. Thellenberg C, Malmer B, Tavelin B, Gronberg H (2003) Second primary cancers in men with prostate cancer: an increased risk of male breast cancer. J Urol 169:1345-1348.
92. Thorstenson YR, Roxas A, Kroiss R, Jenkins MA, Yu KM, Bachrich T, Muhr D, Wayne TL, Chu G, Daws RW, Wagner TM, Oefner PJ (2003) Contributions of ATM mutations to familial breast and ovarian cancer. Cancer Res 63:3325-3333.
93. Vesoulis Z, Kashkari S (1998) Fine needle aspiration of secretory breast carcinoma resembling lactational changes. A case report. Acta Cytol 42:1032-1036.
94. Vetto J, Schmidt W, Pommier R, DiTomasso J, Eppich H, Wood W, Moseson D (1998) Accurate and cost-effective evaluation of breast masses in males. Am J Surg 175:383-387.
95. Volm MD, Talamonti MS, Thangavelu M, Gradishar WK (1997) Pituitary adenoma and bilateral male breast cancer: an unusual association. J Surg Oncol 64:74-78.
96. Volpe CM, Raffetto JD, Collure DW, Hoover EL, Doerr RJ (1999) Unilateral male breast masses: cancer risk and their evaluation and management. Am Surg 65:250-253.
97. Weiderpass E, Gridley G, Persson I, Nyren O, Ekbom A, Adami HO (1997) Risk of endometrial and breast cancer in patients with diabetes mellitus. Int J Cancer 71:360-363.
98. Weiderpass E, Ye W, Adami HO, Vainio H, Trichopoulos D, Nyren O (2001) Breast cancer risk in male alcoholics in Sweden. Cancer Causes Control 12:661-664.
99. Westenend PJ (2003) Core needle biopsy in male breast lesions. J Clin Pathol 56:863-865.
100. Westenend PJ, Jobse C (2002) Evaluation of fine-needle aspiration cytology of breast masses in males. Cancer 96:101-104.
101. Whiteman DC, Murphy MF, Verkasalo PK, Page WF, Floderus B, Skytthe A, Holm NV (2000) Breast cancer risk in male twins: joint analyses of four twin cohorts in Denmark, Finland, Sweden and the United States. Br J Cancer 83:1231-1233.
102. Widmark A, Fossa SD, Lundmo P, Damber JE, Vaage S, Damber L, Wiklund F, Klepp O (2003) Does prophylactic breast irradiation prevent antiandrogen-induced gynaecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3. Urology 61:145-151.
103. Wingren S, van den Heuvel A, Gentile M, Olsen K, Hatschek T, Soderkvist P (1997) Frequent allelic losses on chromosome 13q in human male breast carcinomas. Eur J Cancer 33:2393-2396.
104. Wolpert N, Warner E, Seminsky MF, Futreal A, Narod SA (2000) Prevalence of BRCA1 and BRCA2 mutations in male breast cancer patients in Canada. Clin Breast Cancer 1:57-65.
105. Yang WT, Whitman GJ, Yuen EH, Tse GM, Stelling CB (2001) Sonographic features of primary breast cancer in men. Am J Roentgenol 176:413-416.
106. Yoneda S, Yoshikawa M, Yamane Y, Nakatani T, Iwasawa S, Nishimura K, Watanabe I, Fukui H, Enoki N (2000) Breast cancer developed in a male patient with liver cirrhosis bearing hepatocellular carcinoma. Am J Gastroenterol 95:556-557.